Figure 1

Study population disposition. The flow chart depicts how the selection criteria affect the number of patients remaining in the study sample. Each box represents the number of patients remaining in the sample at each step. From an initial sample of 2,110,735 cancer and 676,712 non-cancer patients, the final sample included 82,832 hematologic, 944,777 solid, and 246,308 non-cancer patients.